Home LiteratureArticle Details
PMID: 9205975 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Long-term perspective on premature infant outcome and contemporary intervention issues.

Seminars in perinatology ·Vol. 21 ·No. 3 ·1997-06-00 ·Pages 190-201

Bennett FC, Scott DT

Abstract

Despite improvements in survival rates for low birthweight (LBW) infants, the prevalence among survivors of major neurodevelopmental impairment seems relatively stable. Cerebral palsy, the most common major impairment, can usually be ruled out by 18 months corrected age. Minor impairments such as learning disabilities cannot be ruled out until much later. The efficacy of interventional services in this population was addressed by a national randomized trial. The intervention produced large treatment effects for heavier LBW infants and moderate effects for lighter infants. Five years later, modest residual effects were found for heavier LBW infants, but not for the lighter, suggesting that 0 to 3 services alone are not sufficient to prevent scholastic disadvantage in this population.

MeSH Terms
Central Nervous System Diseases/epidemiology,therapy Follow-Up Studies Humans Infant, Low Birth Weight Infant, Newborn Infant, Premature, Diseases/epidemiology,therapy Prevalence Randomized Controlled Trials as Topic Time Factors Treatment Outcome
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bennett F C
University of Washington School of Medicine, Seattle 98195-7920, USA.
Scott D T
Article Info
Journal
Seminars in perinatology
Abbr.
Semin Perinatol
ISSN
0146-0005
Published
1997-06-00
Pages
190-201
Language
English
Region
United States
NLM ID
7801132
Subset
IM
Grants
PHS HHS · MCJ 539159 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]